Correlations between blood circulating EVs and clinical-pathological factors including age, sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS), primary tumor location, tumor grading, K-RAS mutation status, liver metastasis, lung metastasis, and number of metastatic sites were explored in the overall patient cohort (Supplementary Table S3). Here, KRAS is linked to neoplasm.